What we do
We are committed to perform cutting edge patient care, research and teaching and to enable these activities by curiosity-driven and clinic-driven laboratory and clinical research that is ambitious and of high scientific quality.

Research
Our research program ranges from fundamental biology to clinical translation and aims to improve diagnostics and treatment in immune-related diseases, including transplant rejection, immunodeficiency, autoimmunity and cancer.

News
-
February 9, 2026 -
January 19, 2026SPARC consortium, including dr. Martijn Verdoes, awarded funding for NWO Perspectief Project
-
January 14, 2026IMMU Toast 2026 Opens the Year with Reflection, Appreciation, and Ambition
-
January 8, 2026Prof. Frank Staal and Dr. Sander de Kivit receive an €50.000 Open Competition Domain Science- XS Grant from the NWO (The Dutch Research Council)
-
January 6, 2026IMMU Science Retreat 2025: A Day of Scientific Exchange, Inspiration, and Collaboration
-
December 3, 2025Global Recognition of Prof. Staal’s Gene Therapy Leadership